Enzyme-Encapsulated Nanoparticles for Immune Shielding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current enzyme-based therapies for conditions like cancer and gout face challenges due to immune responses, toxicity, and limited circulation half-life, leading to ineffective delivery and rapid clearance of enzymes, which compromises treatment efficacy and increases side effects.
Innovation Solution
The development of enzyme-encapsulated nanoparticles, specifically synthetic hollow enzyme-loaded nanospheres (SHELS), which encapsulate enzymes within a shell structure with a hollow interior and porous external layer, preventing enzyme escape while allowing smaller molecules to pass through, thereby protecting enzymes from antibodies and maintaining bioactivity for targeted delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If enzymes are administered directly for therapy, then treatment can be provided, but immune responses occur and circulation half-life is limited
Solution Approach 1:
The enzyme is encapsulated within the hollow interior region of the nanoparticle shell structure, creating a nested configuration where the therapeutic enzyme is protected inside the nanoparticle carrier. This nesting approach extends circulation half-life by shielding the enzyme from immune recognition while maintaining therapeutic functionality.
Solution Approach 2:
The nanoparticle employs a shell structure with an internal layer and external porous layer that acts as a protective barrier. This shell configuration extends enzyme circulation by preventing immune system access while allowing controlled substance transport through the porous external layer.
2Adaptability or versatility
If enzymes are delivered systemically, then therapeutic coverage is achieved, but toxicity increases due to rapid clearance and immune response
Solution Approach 1:
The nanoparticle shell structure serves as an intermediary carrier between the immune system and the therapeutic enzyme. It mediates the delivery process by protecting the enzyme from immune attack while enabling controlled interaction with target tissues through the porous external layer, thereby reducing toxicity.
Solution Approach 2:
The hollow interior region of the nanoparticle creates an inert protective environment for the encapsulated enzyme, isolating it from harmful immune components in the bloodstream. This protected environment maintains enzyme stability and reduces immune-mediated toxicity during systemic circulation.
3Ease of operation
If the nanoparticle shell is made porous to allow substance exchange, then smaller molecules can pass through, but enzyme escape risk increases
Solution Approach 1:
The shell structure exhibits different properties at different locations: the internal layer provides enzyme containment while the external layer is porous for substance exchange. This spatial differentiation of properties allows simultaneous achievement of enzyme containment and substance exchange functionality.
Solution Approach 2:
The external layer is constructed from porous material with controlled pore sizes that permit passage of small molecules and substrates while physically blocking the larger enzyme molecules. This porous structure enables selective transport based on molecular size, maintaining enzyme containment while allowing necessary substance exchange.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the circulation and bioactivity of enzymes, reduces immune response, and achieves sustained therapeutic effects with reduced toxicity, enabling more effective and manageable treatment of conditions like cancer and gout by ensuring prolonged enzyme activity and targeted delivery.
Implementation Method 1
the porous material of the external layer is structured to prevent the enzyme from passing through the external layer while permitting a substance smaller than the enzyme to pass through the pores
Implementation Method 2
the nanoscale structures are structured to initiate cavitation of microscale bubbles when ultrasonic acoustic energy is applied at the nanoparticle
Implementation Method 3
the enzyme contained within the interior region of the shell structure is structured to catalyze a reactive oxidative species (ROS) to decompose and produce oxygen inside the interior region
Implementation Method 4
a fluorophore attached to the shell structure and that emits an optical fluorescent signal based at least on the concentration of a chemical reactant or chemical product of a catalytic interaction
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
Disclosed are methods, systems, and devices for implementing nanoparticles to encapsulate biomolecules such as enzymes. In one aspect, a nanoparticle device includes a shell structure including an internal layer structured to enclose a hollow interior region and include one or more holes penetrating through the internal layer, and an external layer formed of a porous material around the internal layer; and an enzyme contained within the interior region of the shell structure, the enzyme having entered the shell structure through the one or more holes and incapable of passing through the external layer, in which the pores are of a size that prevents the enzyme to pass through the pores while permitting substances smaller than the pore size to pass through the pores.